Legal Representation
Attorney
Lisel M. Ferguson
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 19, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 19, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 6, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 6, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 6, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 6, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 6, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 6, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 6, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 14, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 13, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 13, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 6, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 30, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 20, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 17, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jan 22, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Online retail store services featuring maple cream in the nature of pastry cream made of maple, maple sugar, and maple confections, namely, candy made with maple
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
CARY & MAIN CO.; CARY AND MAIN CO.
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CO."